108 related articles for article (PubMed ID: 32632990)
1. Evaluation of cytopathological screening results and risk factors of women who underwent Papanicolaou test in a maternity school in Fortaleza, Ceará, Brazil.
Tavares MDC; Nicol AF; Yokobatake ER; Melo MML; Vitoriano BF; Carvalho-Costa FA; Martinelli KG; de Paula VS
Cytopathology; 2020 Nov; 31(6):586-592. PubMed ID: 32632990
[TBL] [Abstract][Full Text] [Related]
2. Knowledge, Attitudes and Practices of Sudanese Women Regarding the Pap Smear Test and Cervical Cancer.
Almobarak AO; Elbadawi AA; Elmadhoun WM; Elhoweris MH; Ahmed MH
Asian Pac J Cancer Prev; 2016; 17(2):625-30. PubMed ID: 26925654
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of cervical cancer and pre-cancerous lesions among unscreened Women in Kumasi, Ghana.
Donkoh ET; Agyemang-Yeboah F; Asmah RH; Wiredu EK
Medicine (Baltimore); 2019 Mar; 98(13):e14600. PubMed ID: 30921178
[TBL] [Abstract][Full Text] [Related]
4. [New guidelines in regard to cervical cancer screening].
Vargas-Hernández VM; Acosta-Altamirano G; Moreno-Eutimio MA; Vargas-Aguilar VM
Cir Cir; 2014; 82(4):453-9. PubMed ID: 25167359
[TBL] [Abstract][Full Text] [Related]
5. Knowledge, attitudes, and practices toward cervical cancer prevention among women in Kampong Speu Province, Cambodia.
Touch S; Oh JK
BMC Cancer; 2018 Mar; 18(1):294. PubMed ID: 29544466
[TBL] [Abstract][Full Text] [Related]
6. Human Papillomavirus Vaccination and Pap Smear Uptake Among Young Women in the United States: Role of Provider and Patient.
Guo F; Hirth JM; Berenson AB
J Womens Health (Larchmt); 2017 Oct; 26(10):1114-1122. PubMed ID: 28841084
[TBL] [Abstract][Full Text] [Related]
7. Cervical Screening and Colposcopy Management of Women Age 24 and Under.
Buick C; Jembere N; Wang L; Kupets R
J Obstet Gynaecol Can; 2020 Dec; 42(12):1518-1524. PubMed ID: 32988802
[TBL] [Abstract][Full Text] [Related]
8. Promising strategies for cervical cancer screening in the post-human papillomavirus vaccination era.
Tota J; Mahmud SM; Ferenczy A; Coutlée F; Franco EL
Sex Health; 2010 Sep; 7(3):376-82. PubMed ID: 20719230
[TBL] [Abstract][Full Text] [Related]
9. T Cell Receptor Repertoires Acquired
Christley S; Ostmeyer J; Quirk L; Zhang W; Sirak B; Giuliano AR; Zhang S; Monson N; Tiro J; Lucas E; Cowell LG
Front Immunol; 2021; 12():624230. PubMed ID: 33868241
[TBL] [Abstract][Full Text] [Related]
10. History of high-risk HPV and Pap test results in a large cohort of patients with invasive cervical carcinoma: experience from the largest women's hospital in China.
Tao X; Griffith CC; Zhou X; Wang Z; Yan Y; Li Z; Zhao C
Cancer Cytopathol; 2015 Jul; 123(7):421-7. PubMed ID: 25955972
[TBL] [Abstract][Full Text] [Related]
11. Cervical cancer prevention in Senegal: an International Cooperation Project Report.
Gabrielli S; Maggioni E; Fieschi L
Acta Biomed; 2018 Jul; 89(6-S):29-34. PubMed ID: 30038201
[TBL] [Abstract][Full Text] [Related]
12. Age at last screening and remaining lifetime risk of cervical cancer in older, unvaccinated, HPV-negative women: a modelling study.
Malagón T; Kulasingam S; Mayrand MH; Ogilvie G; Smith L; Bouchard C; Gotlieb W; Franco EL
Lancet Oncol; 2018 Dec; 19(12):1569-1578. PubMed ID: 30392810
[TBL] [Abstract][Full Text] [Related]
13. Cervical cancer screening among young adult women in the United States.
Roland KB; Benard VB; Soman A; Breen N; Kepka D; Saraiya M
Cancer Epidemiol Biomarkers Prev; 2013 Apr; 22(4):580-8. PubMed ID: 23355601
[TBL] [Abstract][Full Text] [Related]
14. Oncogenic human papilloma virus and cervical pre-cancerous lesions in brothel-based sex workers in India.
Sarkar K; Bhattacharya S; Bhattacharyya S; Chatterjee S; Mallick AH; Chakraborti S; Chatterjee D; Bal B
J Infect Public Health; 2008; 1(2):121-8. PubMed ID: 20701853
[TBL] [Abstract][Full Text] [Related]
15. Predictors of Cervical Cancer Screening Among Infrequently Screened Women Completing Human Papillomavirus Self-Collection: My Body My Test-1.
Lea CS; Perez-Heydrich C; Des Marais AC; Richman AR; Barclay L; Brewer NT; Smith JS
J Womens Health (Larchmt); 2019 Aug; 28(8):1094-1104. PubMed ID: 30874477
[No Abstract] [Full Text] [Related]
16. Should cervical cancer screening begin at age 21 for everyone? A quantitative analysis in a high-risk, low-income, African American/Hispanic young-adult population.
Saeed-Vafa D; Huang Y; Manucha V
Diagn Cytopathol; 2014 Mar; 42(3):205-12. PubMed ID: 23897742
[TBL] [Abstract][Full Text] [Related]
17. Glandular Lesions of the Cervix in Clinical Practice: A Cytology, Histology, and Human Papillomavirus Correlation Study From 2 Institutions.
Miller RA; Mody DR; Tams KC; Thrall MJ
Arch Pathol Lab Med; 2015 Nov; 139(11):1431-6. PubMed ID: 25951104
[TBL] [Abstract][Full Text] [Related]
18. Urinary HPV DNA testing as a tool for cervical cancer screening in women who are reluctant to have a Pap smear in France.
Lefeuvre C; Pivert A; Guillou-Guillemette HL; Lunel-Fabiani F; Veillon P; Le Duc-Banaszuk AS; Ducancelle A
J Infect; 2020 Aug; 81(2):248-254. PubMed ID: 32413363
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of human papillomavirus genotype among Moroccan women during a local screening program.
Alhamany Z; El Mzibri M; Kharbach A; Malihy A; Abouqal R; Jaddi H; Benomar A; Attaleb M; Lamalmi N; Cherradi N
J Infect Dev Ctries; 2010 Nov; 4(11):732-9. PubMed ID: 21252451
[TBL] [Abstract][Full Text] [Related]
20. Cervical cancer screening in former sex workers in ex-localization area.
Wardhana A; Dahliana A; Angkawidjaja KM
Afr J Reprod Health; 2023 Feb; 27(2):45-48. PubMed ID: 37584938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
